Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lassen

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Thrombosis Research|May 18, 2013
Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verificationFredrik Wexels, Anniken Haslund, Ola E Dahl, et al.
Thrombosis Research|May 15, 2014
Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolismFredrik Wexels, Ola E Dahl, Are H Pripp, et al.
Journal of Thrombosis and Haemostasis : JTH|January 22, 2010
Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2)B I Eriksson, A G G Turpie, M R Lassen, et al.
Annals of Surgery|December 31, 2013
Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trialAjay K Kakkar, Giancarlo Agnelli, William Fisher, et al.
Inorganic Chemistry|December 5, 2006
Synthesis and vibrational circular dichroism of enantiopure chiral oxorhenium(V) complexes containing the hydrotris(1-pyrazolyl)borate ligandPeter R Lassen, Laure Guy, Iyad Karame, et al.
The New England Journal of Medicine|February 17, 2012
Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancerGiancarlo Agnelli, Daniel J George, Ajay K Kakkar, et al.
Thrombosis and Haemostasis|October 25, 2013
A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustmentAlexander G G Turpie, Sylvia Haas, Reinhold Kreutz, et al.
JACC. Clinical Electrophysiology|April 22, 2022
Multielectrode Unipolar Voltage Mapping and Electrogram Morphology to Identify Post-Infarct Scar Geometry: Validation by HistologyClaire A Glashan, Bawer J Tofig, Hans Beukers, et al.
Journal of Thrombosis and Haemostasis : JTH|December 17, 2003
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS studyB I Eriksson, G Agnelli, A T Cohen, et al.
Acta Orthopaedica Scandinavica|February 1, 1991
Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placeboM R Lassen, L C Borris, H M Christiansen, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Thrombosis Research|May 18, 2013
Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verificationFredrik Wexels, Anniken Haslund, Ola E Dahl, et al.
Thrombosis Research|May 15, 2014
Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolismFredrik Wexels, Ola E Dahl, Are H Pripp, et al.
Journal of Thrombosis and Haemostasis : JTH|January 22, 2010
Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2)B I Eriksson, A G G Turpie, M R Lassen, et al.
Annals of Surgery|December 31, 2013
Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trialAjay K Kakkar, Giancarlo Agnelli, William Fisher, et al.
Inorganic Chemistry|December 5, 2006
Synthesis and vibrational circular dichroism of enantiopure chiral oxorhenium(V) complexes containing the hydrotris(1-pyrazolyl)borate ligandPeter R Lassen, Laure Guy, Iyad Karame, et al.
The New England Journal of Medicine|February 17, 2012
Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancerGiancarlo Agnelli, Daniel J George, Ajay K Kakkar, et al.
Thrombosis and Haemostasis|October 25, 2013
A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustmentAlexander G G Turpie, Sylvia Haas, Reinhold Kreutz, et al.
JACC. Clinical Electrophysiology|April 22, 2022
Multielectrode Unipolar Voltage Mapping and Electrogram Morphology to Identify Post-Infarct Scar Geometry: Validation by HistologyClaire A Glashan, Bawer J Tofig, Hans Beukers, et al.
Journal of Thrombosis and Haemostasis : JTH|December 17, 2003
The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS studyB I Eriksson, G Agnelli, A T Cohen, et al.
Acta Orthopaedica Scandinavica|February 1, 1991
Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placeboM R Lassen, L C Borris, H M Christiansen, et al.
Pageof 14